Literature DB >> 16325297

The determinants of plasma plasminogen activator inhibitor-1 levels differ for American and Japanese men aged 40-49.

Tomoko Takamiya1, Takashi Kadowaki, Wahid R Zaky, Hirotsugu Ueshima, Rhobert W Evans, Tomonori Okamura, Atsunori Kashiwagi, Yasuyuki Nakamura, Yoshiyuki Kita, Russell P Tracy, Lewis H Kuller, Akira Sekikawa.   

Abstract

BACKGROUND: Elevated plasma plasminogen activator inhibitor-1 (PAI-1) levels were associated with higher incidence of type II diabetes. Elucidating the determinants of PAI-1 in various ethnicities may help to understand the susceptibility to developing diabetes. The aim of our study was to compare PAI-1 levels between Americans and the Japanese in the post-war generation and to elucidate the determinants of the PAI-1 levels.
METHODS: We conducted a cross-sectional study on a total of 198 men aged 40-49 in the US (Body mass index (BMI): 27.0+/-3.3 kg/m(2)) and Japan (BMI: 23.3+/-3.1 kg/m(2)). Examination included physique measurement (BMI and waist girth), blood analysis (lipid profiles, glucose, insulin, C-reactive protein, and PAI-1), and life-style assessment by self-administered questionnaires.
RESULTS: PAI-1 levels were significantly lower in American than in Japanese men, even after adjustment for age, waist girth, cigarette smoking, habitual alcohol drinking, and other factors. In the Americans, waist girth, insulin, and cigarette smoking were significantly associated with PAI-1 levels, while waist girth and triglycerides were significantly associated with PAI-1 levels in the Japanese.
CONCLUSIONS: PAI-1 levels were significantly lower in American than in Japanese men and the determinants of PAI-1 levels differ for American and Japanese men aged 40-49.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16325297      PMCID: PMC3660558          DOI: 10.1016/j.diabres.2005.10.015

Source DB:  PubMed          Journal:  Diabetes Res Clin Pract        ISSN: 0168-8227            Impact factor:   5.602


  35 in total

1.  Ethnicity affects the postprandial regulation of glycogenolysis.

Authors:  A Balasubramanyam; S McKay; P Nadkarni; A S Rajan; A Garza; V Pavlik; J A Herd; F Jahoor; P J Reeds
Journal:  Am J Physiol       Date:  1999-11

Review 2.  Increased plasminogen activator inhibitor-1 and vasculopathy. A reconcilable paradox.

Authors:  B E Sobel
Journal:  Circulation       Date:  1999-05-18       Impact factor: 29.690

3.  Effect of tumor necrosis factor alpha and transforming growth factor beta 1 on plasminogen activator inhibitor-1 secretion from subcutaneous and omental human fat cells in suspension culture.

Authors:  H Gottschling-Zeller; M Birgel; K Röhrig; H Hauner
Journal:  Metabolism       Date:  2000-05       Impact factor: 8.694

4.  Much lower prevalence of coronary calcium detected by electron-beam computed tomography among men aged 40-49 in Japan than in the US, despite a less favorable profile of major risk factors.

Authors:  Akira Sekikawa; Hirotsugu Ueshima; Wahid Riad Zaky; Takashi Kadowaki; Daniel Edmundowicz; Tomonori Okamura; Kim Sutton-Tyrrell; Yasuyuki Nakamura; Katsuya Egawa; Hideyuki Kanda; Atsunori Kashiwagi; Yoshiyuki Kita; Hiroshi Maegawa; Kenichi Mitsunami; Kiyoshi Murata; Yoshihiko Nishio; Shinji Tamaki; Yoshiki Ueno; Lewis H Kuller
Journal:  Int J Epidemiol       Date:  2004-11-24       Impact factor: 7.196

5.  Strategies to identify adults at high risk for type 2 diabetes: the Diabetes Prevention Program.

Authors: 
Journal:  Diabetes Care       Date:  2005-01       Impact factor: 19.112

6.  Genotype frequency of plasminogen activator inhibitor-1 (PAI-1) 4G/5G polymorphism in healthy Japanese males and its relation to PAI-1 levels.

Authors:  Y Matsubara; M Murata; I Isshiki; R Watanabe; T Zama; G Watanabe; K Watanabe; Y Ikeda
Journal:  Int J Hematol       Date:  1999-01       Impact factor: 2.490

Review 7.  PAI-1, obesity, insulin resistance and risk of cardiovascular events.

Authors:  I Juhan-Vague; M C Alessi
Journal:  Thromb Haemost       Date:  1997-07       Impact factor: 5.249

8.  Relative contribution of insulin and its precursors to fibrinogen and PAI-1 in a large population with different states of glucose tolerance. The Insulin Resistance Atherosclerosis Study (IRAS).

Authors:  A Festa; R D'Agostino; L Mykkänen; R P Tracy; D J Zaccaro; C N Hales; S M Haffner
Journal:  Arterioscler Thromb Vasc Biol       Date:  1999-03       Impact factor: 8.311

Review 9.  Obesity and impaired fibrinolysis: role of adipose production of plasminogen activator inhibitor-1.

Authors:  T Skurk; H Hauner
Journal:  Int J Obes Relat Metab Disord       Date:  2004-11

10.  Visceral fat accumulation is an important determinant of PAI-1 levels in young, nonobese men and women: modulation by cross-sex hormone administration.

Authors:  E J Giltay; J M Elbers; L J Gooren; J J Emeis; T Kooistra; H Asscheman; C D Stehouwer
Journal:  Arterioscler Thromb Vasc Biol       Date:  1998-11       Impact factor: 8.311

View more
  2 in total

1.  Associations of D-dimer and von Willebrand factor with atherosclerosis in Japanese and white men.

Authors:  Ryoko W Azuma; Takashi Kadowaki; Aiman El-Saed; Hirotsugu Ueshima; Kim Sutton-Tyrrell; Yasuyuki Nakamura; Daniel Edmundowicz; Yoshiki Ueno; Rhobert W Evans; Aya Kadota; Lewis H Kuller; Kiyoshi Murata; Tomoko Takamiya; Sayaka Kadowaki; J David Curb; Akira Sekikawa
Journal:  Acta Cardiol       Date:  2010-08       Impact factor: 1.718

Review 2.  Coronary artery calcification by computed tomography in epidemiologic research and cardiovascular disease prevention.

Authors:  Akira Sekikawa; J David Curb; Daniel Edmundowicz; Tomonori Okamura; Jina Choo; Akira Fujiyoshi; Kamal Masaki; Katsuyuki Miura; Lewis H Kuller; Chol Shin; Hirotsugu Ueshima
Journal:  J Epidemiol       Date:  2012-04-07       Impact factor: 3.211

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.